Manuela Labbozzetta - Concepedia

Author

Manuela Labbozzetta

University of Palermo

Also Known As

M. Labbozzetta, MANUELA LABBOZZETTA, Manuela Labbozzetta, NOTARBARTOLO DI VILLAROSA, Monica

Publications

982

Citations

H-Index

Concepts

All Affiliations

University of Palermo Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy University of Ferrara University of Antananarivo East Carolina University

About

Manuela Labbozzetta is an author at University of Palermo specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	481
2	Natural Sciences	3	3	87
3	Health Sciences	2	2	44
4	Biochemistry	2	2	56
5	Biomedical Engineering	1	1	31

Manuela Labbozzetta

Publications

859

Citations

H-Index

Page 1

	Year	Citations
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells Daniele Simoni, Michele Rizzi, Riccardo Rondanin, Bioorganic & Medicinal Chemistry Letters Tumor BiologyMedicinal ChemistryOncologyMedicineβ-Diketone Modified Analogs	2007	87
The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis Paola Poma, Monica Notarbartolo, Manuela Labbozzetta, International Journal of Molecular Medicine	2007	67
Curcumin as a Possible Lead Compound against Hormone‐Independent, Multidrug‐Resistant Breast Cancer Manuela Labbozzetta, Monica Notarbartolo, Paola Poma, Annals of the New York Academy of Sciences	2009	59
NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers Paola Poma, Manuela Labbozzetta, Natale D’Alessandro, OMICS A Journal of Integrative Biology Breast OncologyChemoprevention StrategyImmunologyTnbc Cell LinesCancer Biology	2017	56
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities Manuela Labbozzetta, Riccardo Baruchello, Paolo Marchetti, Chemico-Biological Interactions Medicinal ChemistryPyrazole DiketoneMedicineNucleophilic AdditionChemosensitizing Activities	2009	54
Expression of WISPs and of Their Novel Alternative Variants in Human Hepatocellular Carcinoma Cells Melchiorre Cervello, Lydia Giannitrapani, Manuela Labbozzetta, Annals of the New York Academy of Sciences	2004	53
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients. Alessio Provenzani, Monica Notarbartolo, Manuela Labbozzetta, PubMed	2009	45
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement Gianfranco Fontana, Maurizio Bruno, Monica Notarbartolo, Bioorganic Chemistry HepatologyChemoprevention StrategyNf-κb InvolvementMedicinePathology	2019	42
Antitumor effects of the novel NF-κB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production Paola Poma, Monica Notarbartolo, Manuela Labbozzetta, International Journal of Oncology Pro-survival GenesChemoprevention StrategyImmunologyPathologyCancer Biology	2006	36
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia Manuela Labbozzetta, Paola Poma, Marco Tutone, Pharmaceuticals	2022	35

Page 1